- Visibility 125 Views
- Downloads 120 Downloads
- Permissions
- DOI 10.18231/j.ijced.25158.1758867585
-
CrossMark
Quality of life, stress and depression in young adult with psoriasis – A cross sectional study
- Author Details:
-
Balaguru Natarajan
-
Sarin Abdulsalam
-
Anjugam Alagappan
-
Asokan Neelakandhan
-
Ajith Kidangazhiathmana
Balaguru Natarajan
Background: Psoriasis is a chronic, relapsing, inflammatory, immune-mediated cutaneous condition. Quality of life is largely affected in patients with psoriasis because of its visibility, cosmetic disfigurement, and social stigma, especially in young adults. There are several studies on the inter-relationship of psoriasis, quality of life, stress, and depression, but only a few of these are in the younger population. This study attempted to bridge this gap in knowledge.
Materials and Methods: A cross-sectional analytical study was conducted to assess the relationship between quality of life using Dermatology life quality index (DLQI), level of stress using psoriasis life stress inventory (PLSI) and depression using Primary care Screening Questionnaire For Depression (PSQ4D) among patients with psoriasis for a duration of at least three months in the age group of 18-35 years.
Results: Seventy patients were included in the study. Forty-five (64.3%) reported having stress. Forty-seven (67.1%) patients had moderate to severe reduction in quality of life. Thirty-two patients (45.7%) had a PSQ4D score of 2 or more indicating depression. Depression had a positive correlation with the severity of psoriasis (r = 0.025). There was a significant association between moderate to severe reduction in quality of life with systemic co-morbidities (p= 0.046) and stress (p=0.002, r = 0.232).
Conclusion: In this study, we found that about 50% of young patients with psoriasis irrespective of gender had a poor quality of life, associated stress, and depression. Treatment of psoriasis entail providing psychosocial support to the patients, besides drugs.
References
- Griffith CE, Barker J N. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263–71.
- Griffiths CEM, Barker JNWN, Tanya B, Robert C. Psoriasis. In: Burden David, Kirby Brian. Rook’s Textbook of Dermatology.UK: 9th ed. Blackwell Publications Ltd; 2016.p35.1.
- Johann EG, James TE. Psoriasis. In: LowellAG, Stephen IK, Barbara AG, Amy SP, David JL, Wolff K. Fitzpatrick’s Dermatology in General Medicine. 8thed. New York: McGraw Hill;2102.p208.
- Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: A preliminary index of psoriasis-related stress. Acta Derm Venereol. 1995;75(3):240–3.
- Siddappa k, Sacchidanand S. Psoriasis. In: Grover chander, editors. IADVL Textbook of Dermatology.4th ed. Bhalani Publishing House; 2016:1044.
- Gonzalez J, Cunningham K, Perlmutter J, Gottlieb A. Systematic Review of Health-Related Quality of Life in Adolescents with Psoriasis. Dermatology. 2016;232(5):541–49.
- Chamoun A, Goudetsidis L, Poot F, Bourdeaud'hui F, Titeca G. Psoriasis and depression. Rev Med Brux. 2015;36(1):23-8.
- Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GB, et al. The psychological burden of skin diseases: A cross- sectional multicenterstudy among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984–91.
- Ejaz A, Raza N, Iftikhar N, Iftikhar A, Farooq M. Presentation of early onset psoriasis in comparison with late onset psoriasis: A clinical study from Pakistan. Indian J Dermatol Venereol Leprol. 2009;75(1):36–40.
- Ding X, Wang T, Shen Y, Wang X, Zhou C, Tian S, et al. Prevalence of psoriasis in China: A population-based study in six cities. Eur J Dermatol. 2012;22(5):663–7.
- Bo K, Thoresen M, Dalgard F. Smokers report more psoriasis, but not atopic dermatitis or hand eczema: Results from a Norwegian population survey among adults. Dermatology. 2008;216(1):40–5.
- Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. lobal epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–85.
- Higgins E. Alcohol, smoking and psoriasis. Clin Exp Dermatol. 2000;25(2):107–10.
- Hayes J, Koo J. Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol Ther. 2010;23(2):174–80.
- Luca M, Luca A, Musumeci ML, Fiorentini F, Micali G, Calandra C. Psychopathological Variables and Sleep Quality in Psoriatic Patients. Int J Mol Sci. 2016;17(7):1184.
- Duruoz MT, Sunmeli SZ, Ucar O. Topcu E, Duruoz E. Evaluation of sleep quality in psoriatic arthritis patients. Ann Rheum Dis. 2013;72(3):682.
- Chen K, Wang G, Jin H, Xu J, Zhu X, Zheng M, et al. Clinic characteristics of psoriasis in China: a nationwide survey in over 12000 patients. Oncotarget. 2017;8(28):46381–9.
- Nayak PB, Girisha BS, Noronha TM. Correlation between Disease Severity, Family Income, and Quality of Life in Psoriasis: A Study from South India. Indian Dermatol Online J. 2018;9(3):165–9.
- Maari C, Bolduc C, Nigen S, Marchessault P, Bissonnette R. Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: A randomized controlled trial. J Dermatolog Treat. 2014;25(1):57–60.
- Manjula VD, Sreekiran S, Saril PS, Sreekanth MP. A study of psoriasis and quality of life in a tertiary care teaching hospital of kottayam, kerala. Indian J Dermatol. 2011;56(4):403–6.
- Moradi M, Rencz F, Brodszky V, Moradi A, Balogh O, Gulácsi L. Health status and quality of life in patients with psoriasis: An Iranian cross-sectional survey. Arch Iran Med. 2015;18(3):153–9.
- Gaikwad R, Deshpande S, Raje S, Dhamdhere DV, Ghate MR. Evaluation of functional impairment in psoriasis. Indian J Dermatol Venereol Leprol. 2006;72(1):37–40.
- Fortune DG, Richards HL, Main CJ, Griffiths CE. What patients with psoriasis believe about their condition. J Am Acad Dermatol. 1998;39(2 Pt 1):196-201.
- Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ, et al. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol. 2002;4794):512–8.
- Golpour M, Hosseini SH, Khademloo M, Ghasemi M, Ebadi A, Koohkan F, et al. Depression and Anxiety Disorders among Patients with Psoriasis: A Hospital-Based Case-Control Study. Dermatol Res Pract. 2012:381905.
- Devrimci-Ozguven H, Kundakci TN, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol. 2000;14(4):267–71.
- Dowlatshahi EA, Wakkee M, Arends LR, Nijsten T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol. 2014;134(6):1542–51. Natarajan et al. / IP Indian Journal of Clinical and Experimental Dermatology 2025;11(3):315-319 319
- Rabin F, Bhuiyan SI, Islam T, Haque MA, Islam MA. Psychiatric and psychological comorbidities in patients with psoriasis- a review. Mymensingh Med J. 2012;21(4):780–6.